Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer

Abstract BRAF-mutated colorectal cancer correlates with poor prognosis and limited response to standard treatments. Combining immune checkpoint inhibitors with BRAF/MEK inhibitors shows promise against BRAF-mutant melanoma in both preclinical and clinical trials. Therefore, we hypothesized that the...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Eunyoung Tak, Hye-In An, Amy Sinyoung Lee, Kyuyoung Han, Jiwan Choi, Hyung-don Kim, Yong Sang Hong, Sun Young Kim, Eun Kyung Choi, Jeong Eun Kim, Tae Won Kim
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Springer 2025-03-01
Ráidu:	Cancer Immunology, Immunotherapy
Fáttát:	BRAF V600E BRAF inhibitor MEK inhibitor Anti-PD-L1 Immunotherapy
Liŋkkat:	https://doi.org/10.1007/s00262-025-04005-3
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!